The INTERPRET–DD study of diabetes and depression: a protocol

Lloyd, Cathy E.; Sartorius, Norman; Cimino, Larry; Álvarez, Adriana; Braude, M. Guinzbourg de; Rabbani, Golam; Ahmed, Helal Uddin; Papelbaum, Marcelo; Freitas, Sílvia; Ji, Linong; Yu, Xinguang; Gäebel, Wolfgang; Müssig, Karsten; Chaturvedi, Santosh K.; Srikanta, S.; Burti, Lorenzo; Bulgari, Viola; Musau, Abednego; Ndetei, David M.; Heinze, Gerhard; Romo‐Nava, Francisco; Taj, Rizwan; Khan, A.A.; Kokoszka, Andrzej; Papasz-Siemieniuk, A.; Старостина, Е. Г.; Бобров, А. Е.; Lečić-Toševski, Dušica; Lalić, Nebojša; Udomratn, Pichet; Tangwongchai, Sookjaroen; Bahendeka, Silver; Basangwa, David; Mankovsky, Boris

doi:10.1111/dme.12719

Cited by 26 publications

(37 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It included almost 3000 people with a clinical diagnosis of Type 2 diabetes [15]. It included almost 3000 people with a clinical diagnosis of Type 2 diabetes [15].…”

Section: Discussionmentioning

confidence: 99%

“…The situation is even worse when it comes to the comorbidity of mental and physical disorders, which is undoubtedly one of the major problems with regard to healthcare in the 21 st century [35]. In particular the range of available treatments within each local context [15], the awareness of those caring for people with these two conditions, the acceptance of the need and preferences for treatment and the demonstrability of successful outcomes are all important factors that influence the applicability of different therapies in different settings. In particular the range of available treatments within each local context [15], the awareness of those caring for people with these two conditions, the acceptance of the need and preferences for treatment and the demonstrability of successful outcomes are all important factors that influence the applicability of different therapies in different settings.…”

Section: Discussionmentioning

confidence: 99%

“…A full description of the protocol used in the present study is provided in our earlier paper [15]. In brief, between September 2013 and May 2015 a sample of consecutive outpatient clinic attendees with Type 2 diabetes at each of the study sites was invited to participate in the study, with the aim of including 200 people with Type 2 diabetes in each country.…”

Section: Methodsmentioning

confidence: 99%

“…Eligible study participants were adults (aged 18-65 years) with Type 2 diabetes [15] diagnosed at least 12 months What's new?…”

Section: Inclusion/exclusion Criteriamentioning

confidence: 99%

See 3 more Smart Citations

Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries

et al. 2018

Self Cite

View full text Add to dashboard Cite

Our international study, the largest of this type ever undertaken, shows that people with diabetes frequently have depressive disorders and also significant levels of depressive symptoms. Our findings indicate that the identification and appropriate care for psychological and psychiatric problems is not the norm and suggest a lack of the comprehensive approach to diabetes management that is needed to improve clinical outcomes.

show abstract

“…It included almost 3000 people with a clinical diagnosis of Type 2 diabetes [15]. It included almost 3000 people with a clinical diagnosis of Type 2 diabetes [15].…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

“…Eligible study participants were adults (aged 18-65 years) with Type 2 diabetes [15] diagnosed at least 12 months What's new?…”

Section: Inclusion/exclusion Criteriamentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…Our study finding described the effect of various biopsychosocial factors on patient’s mood because depression-related factors frequently missed in people with diabetes [76]. This will improve evidence-based practice for comprehensive management physical and mental illness [77]. …”

Section: Discussionmentioning

confidence: 99%

Comorbidity of depression and diabetes: an application of biopsychosocial model

Islam

Tsige

Tegegne

2016

Int J Ment Health Syst

View full text Add to dashboard Cite

BackgroundType 2 diabetes (T2D) is one of the most psychologically demanding chronic medical illness in adult. Comorbidity between diabetes and depression is quite common, but most studies were based on developed country sample. Limited data exists to document biopsychosocial predictors of depressive symptoms in Ethiopian patients. Therefore, the aim of the study was to describe the association of depressive symptoms and T2D and explore the potential underlying associated biopsychosocial risk factors.MethodsInstitution based cross-sectional study was conducted on 276 patient with T2D at diabetic clinic, Black Lion General Specialized Hospital in Ethiopia. Patients were selected using systematic random sampling technique. Depressive symptoms score, which constructed from a validated nine-item Patient Health Questionnaire (PHQ-9), was an outcome variable. Finally, significant associated factors were identified using multiple linear regression analysis with backward elimination procedure. Statistical Package for Social Science (SPSS) version 22.0 (IBM SPSS Corp.) was used to perform all analysis.ResultsTotal of 264 patient data was analyzed with 95.7% response rate. Patients mean (SD) current age and age at diagnosis was 55.9 (10.9) and 43.9 (10.9) years, respectively. Patients waist circumference (mean ± SD) was 98.9 ± 11.1 cm. The average PHQ-9 score was 4.9 (SD 4.1) and fasting blood glucose was 166.4 (SD 73.2). Marital status (divorced), occupation (housewife), diabetic complication (nephropathy), negative life event in the last six months, and poor social support significantly associated with increased mean PHQ-9 score after adjustment for covariates. Whereas not fearing diabetic-related complication and death significantly lower mean PHQ-9 score.ConclusionBiopsychosocial variables including marital status, negative life event in the last 6 months, occupation, diabetic complication, and poor social support significantly increase average depressive symptoms score. Evidence-based intervention focusing on these identified biopsychosocial factors are necessary to prevent the development of depressive symptoms.Electronic supplementary materialThe online version of this article (doi:10.1186/s13033-016-0106-2) contains supplementary material, which is available to authorized users.

show abstract

Factors associated with withdrawal from insulin pump therapy: A large‐population‐based study

Merzon

Grossman

Vinker

et al. 2020

Diabetes Metabolism Res

View full text Add to dashboard Cite

Background: Although, number of diabetic patients received insulin pump (IP) therapy is increasing; there are limited data regarding factors associated with IP withdrawal.Methods: We conducted a cross-sectional study using data from an Israeli health maintenance organization. All patients, 21 or older, with type 1 (T1DM) or type 2 (T2DM) diabetes, who received IP therapy for a 7-year period were identified.Patients who did not purchase IP maintenance supplies for at least six consecutive months were defined as withdrawn (N = 355). Patients who purchased supplies were defined as adherent (N = 352). Results: In both T1DM and T2DM patients, withdrawal from IP therapy was positively associated with duration of diabetes longer than 5 years (odds ratio [OR] = 13.26 [CI, 7.16-23.34; P < .001] and OR = 10.92 [CI, 5.64-21.14; P < .001], respectively), nonadherence to dietician follow-up (OR = 5.78 [CI, 3.65-9.14; P < .001] and OR = 3.41 [CI, 1.99-5.85; P < .001], respectively), and poor glycaemic control prior to IP treatment (OR = 4.04 [CI, 2.18-7.48; P < .001] and OR = 4.59 [CI, 2.71-7.81; P < .001], respectively]. Co-morbid neuro-psychiatric disorders were also risk factors for IP withdrawal: diagnosis of depression (OR = 2.22 [CI, 1.16-4.27; P = .017] and Attention Deficit Hyperactivity Disorder (ADHD) OR = 2.45 [CI, 1.003-5.087; P = .043]) among T1DM patients; and diagnosis of depression (OR = 1.85 [CI, 1.05-5.27; P = .046] and dementia OR = 4.03 [CI, 1.03-19.77; P = .048]) among T2DM patients. Conclusion: In our large real-world population-based study, we found that smoking, obesity, poor glycaemic control, and co-morbid neuro-psychiatric disorders were associated with a high rate of withdrawal from IP therapy. Health care providers ought to familiarize themselves with patient characteristics predictive of nonadherence and should intensify patient follow-up when incorporating this new, costly, and challenging technology. K E Y W O R D S diabetes mellitus, insulin pump, nonadherence

show abstract

The INTERPRET–DD study of diabetes and depression: a protocol

Cited by 26 publications

References 35 publications

Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries

Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries

Comorbidity of depression and diabetes: an application of biopsychosocial model

Factors associated with withdrawal from insulin pump therapy: A large‐population‐based study

Contact Info

Product

Resources

About